Page 4 - Raymondg Perelman Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CHOP Researchers Develop Versatile and Low-Cost Technology for Targeted Long-read RNA Sequencing

/PRNewswire/ In a development that could accelerate the discovery of new diagnostics and treatments, researchers at Children s Hospital of Philadelphia.

United statesNew jerseyYi xingRaymondg perelman centerNational institutes of healthNature communicationsLaboratory medicineCare networkAlan linAssistant professorMolecular therapeuticsTranscript enrichmentGenomic medicineNational institutes

$25 Million Gift to Penn Medicine and Children s Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders

/PRNewswire/ A $25 million gift from an anonymous donor to Penn Medicine and Children s Hospital of Philadelphia (CHOP) will establish the Center for.

University of pennsylvaniaUnited statesLucy prosserBenjamin prosserIngo helbigDanielb burkeJ larry jamesonMadeline bellStephenb burkeBeverly davidsonHealth systemUniversity of pennsylvania school medicineUniversity of pennsylvania perelman school medicineEpilepsy neurogenetics initiativeTherapeutics teamPerelman school of medicine

$25M Gift Establishes Center for Epilepsy & Neurodevelopmental

$25M Gift Establishes Center for Epilepsy & Neurodevelopmental
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

University of pennsylvaniaUnited statesLucy prosserBenjamin prosserIngo helbigDanielb burkeJ larry jamesonMadeline bellStephenb burkeBeverly davidsonHealth systemUniversity of pennsylvania perelman school medicineEpilepsy neurogenetics initiativeTherapeutics teamPerelman school of medicineRaymondg perelman center

Opus Genetics Acquires Two Gene Therapy Candidates for Treating Blindness | North Carolina Biotechnology Center

RTP gene therapy startup Opus Genetics has acquired the rights to two pre-clinical product candidates to treat inherited retinal diseases from New Jersey biopharm company Iveric Bio.

United statesUnited kingdomNew jerseyNorth carolinaResearch triangle parkUniversity of pennsylvaniaTjean bennettBen yerxaIveric bioBartp leroyCarolina biotechnology centerRaymondg perelman centerManning family foundationRetinal disease fundGenetics at ghent universityGhent university hospital

Opus Genetics Announces Acquisition of the Rights to Two Gene Therapy Product Candidates for Inherited Retinal Diseases

Opus to advance preclinical development programs for BEST1- and RHO-related retinal diseases Opus Genetics, a patient-first, clinical-stage gene therapy company

United statesUnited kingdomHeather andersonBen yerxaIveric bioBartp leroyGhent university hospitalDivision of ophthalmologyHealthcare pharmaceuticals industryRaymondg perelman centerResearch triangle parkRd fundDepartment of ophthalmologyGenetics at ghent universityFoundation fighting blindnesChief executive officer